Sign Up Today and Learn More About Neusignal Therapeutics Stock
Invest in or calculate the value of your shares in Neusignal Therapeutics or other pre-IPO companies through EquityZen's platform.
Neusignal Therapeutics Stock
Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
About Neusignal Therapeutics Stock
Founded
2022
Industries
Apps, Artificial Intelligence, Software
Neusignal Therapeutics Press Mentions
Stay in the know about the latest news on Neusignal Therapeutics
Neusignal Therapeutics、シリーズBで総額53.2億円を調達
prtimes • Jun 30, 2026
KIIがアルツハイマー型認知症治療薬開発のNeusignal Therapeuticsに追加出資
prtimes • Jun 30, 2026
NTX-083健康成人を対象とした第Ⅰ相企業治験（反復投与試験）において安全性及び忍容性の確認が終了
prtimes • Mar 17, 2026
Alzheimer’s Drug Developer Neusignal Therapeutics Raises 2.25 Billion Yen in Series A
thebridge • Feb 07, 2025
Join now and verify your accreditation status to gain access to:
- Neusignal Therapeutics Current Valuation
- Neusignal Therapeutics Stock Price
- Neusignal Therapeutics Management
- Available deals in Neusignal Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Neusignal Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Neusignal Therapeutics Revenue and Financials
- Neusignal Therapeutics Highlights
- Neusignal Therapeutics Business Model
- Neusignal Therapeutics Risk Factors
- Neusignal Therapeutics Research Report from SACRA Research
Trading Neusignal Therapeutics Stock
How to invest in Neusignal Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Neusignal Therapeutics through EquityZen funds. These investments are made available by existing Neusignal Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Neusignal Therapeutics stock?
Shareholders can sell their Neusignal Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."